Norman Gitlin, MD
Enriched profileMedical Co-Director, Atlanta Gastroenterology Associates' Liver Center · Atlanta Gastroenterology Associates (Liver Center)
Norman Gitlin is Medical Co-Director, Atlanta Gastroenterology Associates' Liver Center at Atlanta Gastroenterology Associates (Liver Center). ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 31 Aug 2026
Norman Gitlin, MD, is Medical Co-Director, Atlanta Gastroenterology Associates' Liver Center. The public record shows 146 publications with 9,273 citations (h-index 34), centered on Viral Hepatitis (B/C). It also documents an investigator role on 2 registered clinical trials, industry payments reported by 8 companies.
- Top research focus: Viral Hepatitis (B/C)
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →liverresources.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 31 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Sponsor: Romark Laboratories L.C.
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
Sponsor: Romark Laboratories L.C.
Industry payments
Updated 31 Aug 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year202525 payments$20,818openpaymentsdata.cms.gov ↗
- Ipsen Biopharmaceuticals, IncProgram year20253 payments
- Gilead Sciences, Inc.Program year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
64.3%Thyroid Hormone Receptor beta Agonist20%Rezdiffra100%Part D<11 patientsProton pump inhibitor17.4%Pantoprazole Sodium100%Part D<11 patientsCardiovascular
26.1%Loop diuretic14.8%Furosemide100%Part D<11 patientsACE inhibitor11.3%Lisinopril100%Part D<11 patientsCancer & immunology
9.6%Purine Antimetabolite9.6%Azathioprine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
The Lancet. Gastroenterology & hepatology
2023 - Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study
Hepatology Communications
2021
Online presence
Updated 31 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
liverresources.org/directory-directory/listing/norman-gitlin-md-frcp-facp-facg
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →liverresources.org ↗ - Other
mdatl.com/2014/10/doctor-receives-recognition-for-contributions-study-of-liver-disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdatl.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 31 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →liverresources.org ↗
- Internship
Groote Schuur Hospital, Cape Town, South Africa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →liverresources.org ↗ - Residency and Hepatology Fellowship
Royal Free Hospital, London (under Dame Professor Sheila Sherlock)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →liverresources.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →liverresources.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →liverresources.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →liverresources.org ↗
Editorial & leadership roles
journal and society appointments- Editor
Clinics in Liver Disease (North America)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →liver.theclinics.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →liverresources.org ↗
- Editorial board member
several national gastroenterology/hepatology journals
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →liverresources.org ↗
Awards & honors
honors on the public record- Fellow of the American Association for the Study of Liver Diseases (AASLD)
2014 inaugural class of AASLD Fellows
2014verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdatl.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →liverresources.org ↗
- "Best Teacher and Clinical Attender" award
VA Hospital and Valley Medical Center, Fresno
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →liverresources.org ↗
Secondary affiliations
appointments beyond the home institution- Southern California Liver and GI Centers
San Clemente, CA (physician staff listing)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →livercenters.com ↗ - Emory University School of Medicine
Atlanta, GA, formerly Chief of Hepatology and Professor of Medicine (historical, not current)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →liverresources.org ↗ - University of California
San Francisco (UCSF), prior academic position (nominated by Alpha Omega Alpha at UCSF)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mdatl.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona